Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation

Nephrology

Volumn 13, Issue 1, 2008, Pages 80-86

  Uslu, Adam ^a   Nart, Ahmet ^a,b   Taşli, Funda Alkan ^a   Postaci, Hakan ^a   Aykas, Ahmet ^a   Doǧan, Murat ^a   Şahin, Tamer ^a  

^a Izmir Teaching Hospital   (Turkey)

^b Izmir Ataturk Training and Research Hospital   (Turkey)

Author keywords

Chronic allograft nephropathy; Expanded criteria donor; Sirolimus

Indexed keywords

CREATININE; RAPAMYCIN; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ENDARTERITIS; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RECIPIENT; RECURRENT DISEASE; RENAL GRAFT DYSFUNCTION; SCORING SYSTEM; URINARY TRACT INFECTION;

ADULT; ANTILYMPHOCYTE SERUM; BIOPSY; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIROLIMUS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 38149043613     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00866.x     Document Type: Article

References (13)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 2000 342 : 605 12.
2. Kaplan B, Meier-Kriesche HU. Renal transplantation: A half century of success and the long road ahead. J. Am. Soc. Nephrol. 2004 12 : 3270 71.
3. Nankivell BJ, Borrows RJ, Fung CLS, O'Connell PJ, Allen RDM, Chapman JR. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 2003 349 : 2326 33.
4. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action. Immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin. Biochem. 1998 31 : 335 40.
5. Karpinski J, Lajoie G, Cattran D et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 1999 67 : 1162 7.
6. Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1999 59 : 1683 9.
7. Ojo OA. Expanded criteria donors: Process and outcomes. Semin. Dial. 2005 18 : 463 8.
8. Groth CG, Backman L, Morales JM et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine. Transplantation 1999 67 : 1036 42.
9. Kreis H, Cisterne JM, Land W et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000 69 : 1252 60.
10. Flechner SM, Kurian SM, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am. J. Transplant. 2004 4 : 1776 85.
11. Larson TS, Dean PG, Stegall MD et al. Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus. Am. J. Transplant. 2006 6 : 514 22.
12. Mc Taggart RA, Gottlieb D, Brooks J et al. Comparison of outcomes after delayed graft dysfunction: Sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens. Transplantation 2004 78 : 475.
13. Pelletier R, Nadasdy T, Nadasdy G et al. Acute renal failure following kidney transplantation associated with myoglobinuria in patients treated with rapamycin. Transplantation 2006 82 : 645 50.